Murlo, Italy

Silvia Rossi Paccani

This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Silvia Rossi Paccani. Retrieved from https://idiyas.com/inventor/silvia-rossi-paccani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Silvia Rossi Paccani: Innovator in Immunology

Introduction

Silvia Rossi Paccani is a notable inventor based in Murlo, Italy. She has made significant contributions to the field of immunology, particularly through her research and innovations related to antigens.

Latest Patents

Silvia holds a patent for "Antigens and antigen combinations," which focuses on NTHI protein antigens. These antigens have been identified as conserved across several pathogenic strains. They have been isolated and cloned from a reference strain, and their immunogenicity has been tested. The patent also discloses methods for immunization and vaccines derived from these antigens.

Career Highlights

Silvia Rossi Paccani works at GlaxoSmithKline Biologicals S.A., where she continues to advance her research in immunology. Her work has the potential to impact vaccine development and improve public health outcomes.

Collaborations

Silvia collaborates with esteemed colleagues, including Marco Soriani and Maria Scarselli, who contribute to her research efforts and innovations in the field.

Conclusion

Silvia Rossi Paccani is a pioneering inventor whose work in immunology and patent contributions are shaping the future of vaccine development. Her dedication to research and collaboration highlights the importance of innovation in addressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…